{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T14:24:39Z","timestamp":1793975079685,"version":"4.8.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.ajo.2021.03.042","type":"journal-article","created":{"date-parts":[[2021,5,10]],"date-time":"2021-05-10T22:05:53Z","timestamp":1620684353000},"page":"134-141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"special_numbering":"C","title":["Classification Criteria for Toxoplasmic Retinitis"],"prefix":"10.1016","volume":"228","author":[{"given":"Douglas A.","family":"Jabs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Rubens","family":"Belfort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahram","family":"Bodaghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary N.","family":"Holland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan L.","family":"Lightman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neal","family":"Oden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan G.","family":"Palestine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justine R.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer E.","family":"Thorne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett E.","family":"Trusko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajo.2021.03.042_bib0001","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.ajo.2003.09.040","article-title":"Ocular toxoplasmosis: a global reassessment. Part I. epidemiology and course of the disease","volume":"136","author":"Holland","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2021.03.042_bib0002","first-page":"1","article-title":"Ocular toxoplasmosis; a global reassessment. Part II. Disease manifestations and management","volume":"137","author":"Holland","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2021.03.042_bib0003","doi-asserted-by":"crossref","first-page":"551","DOI":"10.4269\/ajtmh.17-0677","article-title":"Toxoplasma gondii infection in the United States","volume":"98","author":"Jones","year":"2018","journal-title":"Am J Trop Med Hygiene"},{"key":"10.1016\/j.ajo.2021.03.042_bib0004","doi-asserted-by":"crossref","first-page":"464","DOI":"10.4269\/ajtmh.2010.09-0664","article-title":"Annual burden of ocular toxoplasmosis in the US","volume":"82","author":"Jones","year":"2010","journal-title":"Am J Trop Med Hygiene"},{"key":"10.1016\/j.ajo.2021.03.042_bib0005","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0002-9394(14)73976-5","article-title":"An unusually high prevalence of ocular toxoplasmosis in southern Brazil","volume":"114","author":"Glassner","year":"1992","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2021.03.042_bib0006","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S0002-9394(14)76638-3","article-title":"Acquired toxoplasmic infection as the cause of toxoplasmic retinochoroiditis in families","volume":"106","author":"Silveira","year":"1988","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2021.03.042_bib0007","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0002-9394(00)00830-8","article-title":"A follow-up study of Toxoplasma gondii infection in southern Brazil","volume":"131","author":"Silveira","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2021.03.042_bib0008","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.ajo.2015.02.015","article-title":"Ocular involvement following post-natally acquired Toxoplasma gondii infection in Southern Brazil: a 28-year experience","volume":"159","author":"Arantes","year":"2015","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2021.03.042_bib0009","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1001\/archopht.1969.00990010483005","article-title":"Variations in recurrent active toxoplasmic retinochoroiditis","volume":"81","author":"Friedman","year":"1969","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2021.03.042_bib0010","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0161-6420(02)00990-9","article-title":"Ocular toxoplasmosis: clinical features and prognosis of 154 patients","volume":"109","author":"Bosch-Driessen","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2021.03.042_bib0011","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/00055735-200212000-00008","article-title":"Atypical presentations of ocular toxoplasmosis","volume":"13","author":"Smith","year":"2002","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.ajo.2021.03.042_bib0012","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1001\/archopht.1985.01050090084037","article-title":"Punctate outer retinal toxoplasmosis","volume":"103","author":"Doft","year":"1985","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2021.03.042_bib0013","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0161-6420(13)31267-6","article-title":"Ocular toxoplasmosis misdiagnosed as cytomegalovirus retinopathy in immunocompromised patients","volume":"101","author":"Elkins","year":"1994","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2021.03.042_bib0014","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/S0002-9394(02)01324-7","article-title":"Ocular toxoplasmosis after the fifth decade","volume":"133","author":"Labalette","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2021.03.042_bib0015","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1590\/S0074-02762009000200031","article-title":"Ocular toxoplasmosis: the influence of patient age","volume":"104","author":"Holland","year":"2009","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.ajo.2021.03.042_bib0016","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1086\/322800","article-title":"Unusual abundance of atypical strains associated with human ocular toxoplasmosis","volume":"184","author":"Grigg","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ajo.2021.03.042_bib0017","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1093\/infdis\/jit313","article-title":"Toxoplasma serotype is associated with development of ocular toxoplasmosis","volume":"208","author":"Shobab","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ajo.2021.03.042_bib0018","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1016\/S0161-6420(99)90453-0","article-title":"Use of the polymerase chain reaction for diagnosis of ocular toxoplasmosis","volume":"106","author":"Montoya","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2021.03.042_bib0019","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0002-9394(02)01526-X","article-title":"An update on current practices in the management of ocular toxoplasmosis","volume":"134","author":"Holland","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2021.03.042_bib0020","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0002-9394(14)74456-3","article-title":"Therapy for ocular toxoplasmosis","volume":"115","author":"Rothova","year":"1993","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2021.03.042_bib0021","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1016\/j.ophtha.2005.05.025","article-title":"Prospective randomized trial of trimethoprim\/dulfamethoxazole versus pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis","volume":"112","author":"Sohelian","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2021.03.042_bib0022","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ophtha.2010.04.020","article-title":"Randomized trial of intravitreal clindamycin and dexamethasone versus pyrimethamine, sulfadiazine, and prednisone in treatment of ocular toxoplasmosis","volume":"118","author":"Soheilian","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2021.03.042_bib0023","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0002-9394(02)01537-4","article-title":"A prospective, randomized trial of pyimethamine and azithromycin vs pyrimethamine and sulfadiazine for the treatment of ocular toxoplasmosis","volume":"134","author":"Bosch-Driessen","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2021.03.042_bib0024","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/0002-9394(81)90642-5","article-title":"Fulminant ocular toxoplasmosis","volume":"92","author":"Sabates","year":"1981","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2021.03.042_bib0025","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/0002-9394(88)90697-6","article-title":"Ocular toxoplasmosis in patients with the acquired immunodeficiency syndrome","volume":"106","author":"Holland","year":"1988","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2021.03.042_bib0026","first-page":"623","article-title":"Ocular manifestations of HIV infection","author":"Jabs","year":"1995","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.ajo.2021.03.042_bib0027","doi-asserted-by":"crossref","unstructured":"Silveira C, Belfort R Jr, Muccioli C, et al. The effect of long-term intermittent trimethoprim\/sulfamethoxazole treatment on recurrences of toxoplasmic retinochoroiditis. Am J Ophthalmol134:41-46.","DOI":"10.1016\/S0002-9394(02)01527-1"},{"key":"10.1016\/j.ajo.2021.03.042_bib0028","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.ajo.2013.12.022","article-title":"Trimethoprim-sulfamethoxazole versus placebo to reduce the risk of recurrences of Toxoplasma gondii retinochoroiditis: randomized controlled clinical trial","volume":"157","author":"Felix","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2021.03.042_bib0029","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","article-title":"Nussenblatt RB, the Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Report of the first international workshop","volume":"140","author":"Jabs","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2021.03.042_bib0030","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ajo.2013.03.027","article-title":"Approach to the diagnosis of the uveitides","volume":"156","author":"Jabs","year":"2013","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2021.03.042_bib0031","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3414\/ME12-01-0063","article-title":"Standardization of Uveitis Nomenclature Working Group. The SUN Project. Development of a clinical evidence base utilizing informatics tools and techniques","volume":"52","author":"Trusko","year":"2013","journal-title":"Methods Inf Med"},{"key":"10.1016\/j.ajo.2021.03.042_bib0032","first-page":"787","article-title":"The SUN Project. The future is here","volume":"131","author":"Okada","year":"2013","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2021.03.042_bib0033","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ajo.2017.10.028","article-title":"for the Standardization of Uveitis Nomenclature Working Group. Interobserver agreement among uveitis experts on uveitic diagnoses: the Standard of Uveitis Nomenclature experience","volume":"186","author":"Jabs","year":"2018","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2021.03.042_bib0034","article-title":"The Standardization of Uveitis Nomenclature (SUN) Working Group. Development of classification criteria for the uveitides","year":"20210409","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2021.03.042_bib0035","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/acr.22583","article-title":"Distinctions between diagnostic and classification criteria","volume":"67","author":"Aggarwal","year":"2015","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.ajo.2021.03.042_bib0036","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0002-9394(82)90070-8","article-title":"The role of hypersensitivity reactions to toxoplasma antigens in experimental ocular toxoplasmosis in nonhuman primates","volume":"94","author":"Newman","year":"1982","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2021.03.042_bib0037","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0002-9394(14)70986-9","article-title":"Eye manifestations of congenital toxoplasmosis","volume":"123","author":"Mets","year":"1997","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2021.03.042_bib0038","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.ajo.2008.09.006","article-title":"Intraocular inflammation associated with ocular toxoplasmosis: relationships at initial examination","volume":"146","author":"Dodds","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2021.03.042_bib0039","doi-asserted-by":"crossref","first-page":"947","DOI":"10.2307\/3285833","article-title":"Detection of Toxoplasma gondii parasitemia in experimentally inoculated cats","volume":"85","author":"Burney","year":"1999","journal-title":"J Parasitol"},{"key":"10.1016\/j.ajo.2021.03.042_bib0040","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1128\/jcm.31.9.2327-2331.1993","article-title":"Diagnosis of Toxoplasma parasitemia in patients with AIDS by gene detection after amplification with polymerase chain reaction","volume":"31","author":"Filice","year":"1993","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ajo.2021.03.042_bib0041","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ajo.2005.09.017","article-title":"Polymerase chain reaction and Goldmann-Witmer coefficient analysis are complimentary for the diagnosis of infectious uveitis","volume":"141","author":"De Groot-Mijnes","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2021.03.042_bib0042","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.ophtha.2007.05.014","article-title":"Usefulness of aqueous humor analysis for diagnosis of posterior uveitis","volume":"115","author":"Rothova","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2021.03.042_bib0043","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1128\/JCM.01900-07","article-title":"Comparison of immunoblotting, calculation of the Goldmann-Witmer coefficient, and real-time PCR using aqueous humor samples for diagnosis of ocular toxoplasmosis","volume":"46","author":"Fekkar","year":"2008","journal-title":"J Clin Microbiol"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939421001677?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939421001677?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:43:02Z","timestamp":1762080182000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939421001677"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":43,"alternative-id":["S0002939421001677"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2021.03.042","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Classification Criteria for Toxoplasmic Retinitis","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2021.03.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}